It was reported that the patient presented with a 100% thrombotic occlusion in the right coronary artery.Thrombus aspiration was performed and pre-dilatation was performed with a 2.5mm balloon.The 4.0x23 mm xience prime stent was implanted successfully.The stent was post-dilated with a 4.5 mm balloon dilatation catheter (bdc).The same day, the patient experienced excessive sweating, and a drop in blood pressure.Medication was administered for the blood pressure and the patient was intubated.The patient expired due to a suspected stent thrombosis.No additional information was provided.
|
The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effects of death, hypotension and thrombosis is listed in the xience prime, everolimus eluting coronary stent systems instructions for use as known patient effects of coronary stenting procedures.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.However, the treatment appears to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|